Supplementary Online Content

Similar documents
Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

Supplementary Table S1: Proportion of missing values presents in the original dataset

Supplementary Online Content

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease

Supplementary Online Content

Supplementary Online Content

Supplement materials:

Person-years; number of study participants (number of cases) HR (95% CI) P for trend

Supplementary Online Content

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

SUPPLEMENTAL MATERIAL

4. Which survey program does your facility use to get your program designated by the state?

BECAUSE OF THE BENEFIT OF

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Supplementary Online Content

Preventive Cardiology Scientific evidence

Since 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.

The Muscatine Study Heart Health Survey

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Appendix: Supplementary tables [posted as supplied by author]

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Supplementary Online Content

Supplementary Appendix

Downloaded from:

Supplementary Online Content

Chapter 4: Cardiovascular Disease in Patients With CKD

Supplementary Online Content

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

Guidelines on cardiovascular risk assessment and management

Supplementary Online Content

Supplementary Online Content

Coronary Artery Disease Clinical Practice Guidelines

Practice-Level Executive Summary Report

Clinical Practice Guideline

Hormone therapy. Dr. med. Frank Luzuy

Several studies have reported that people with periodontal

Supplementary Appendix

Quality Payment Program: Cardiology Specialty Measure Set

Supplementary Online Content

DUKECATHR Dataset Dictionary

Supplementary Online Content

ORIGINAL INVESTIGATION. The Impact of Diabetes Mellitus on Mortality From All Causes and Coronary Heart Disease in Women

Supplementary Online Content

Supplementary Online Content

Supplementary material

Supplementary Online Content

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Consideration of Anthropometric Measures in Cancer. S. Lani Park April 24, 2009

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

MEAT IS A MAJOR SOURCE

Quality Payment Program: Cardiology Specialty Measure Set

VI. Behavioral Concerns

Association of Changes in Diet Quality with Total and Cause-Specific Mortality

Supplementary Appendix

Rotating night shift work and risk of psoriasis in US women

Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts 1 3

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Combined oral contraceptives and risk of venous thromboembolism: nested case control studies using the QResearch and the CPRD databases

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)?

Clinical Quality Measures

The New England Journal of Medicine PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE. Population

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

EFFECTIVENESS OF PHONE AND LIFE- STYLE COUNSELING FOR LONG TERM WEIGHT CONTROL AMONG OVERWEIGHT EMPLOYEES

Meaningful Use Clinical Quality Measures for Eligible Professionals

The New England Journal of Medicine

The MAIN-COMPARE Study

Supplementary Online Content

Patient characteristics Intervention Comparison Length of followup

Looking Toward State Health Assessment.

Preventing Myocardial Infarction in the Young Adult in the First Place: How Do the National Cholesterol Education Panel III Guidelines Perform?

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Antihypertensive Trial Design ALLHAT

Risk Factors for Mortality in the Nurses Health Study: A Competing Risks Analysis

ORIGINAL INVESTIGATION. Self-Selected Posttrial Aspirin Use and Subsequent Cardiovascular Disease and Mortality in the Physicians Health Study

Supplementary Online Content

Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

Pre-diagnostic cruciferous vegetables intake and lung cancer survival among Chinese women

SUPPLEMENTAL MATERIAL

Correlation of LV Longitudinal Strain by 2D Speckle Tracking with Cardiovascular risk in Elderly. (A pilot study of EGAT-Echo study.

Consensus Core Set: Cardiovascular Measures Version 1.0

SUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index

Coronary Heart Disease in Women Go Red for Women

Transcription:

Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768. etable. Multivariate adjusted hazard ratios for all-cause and cardiovascular mortality according to simple-updated post-mi (without alcohol component), changes from pre- to post-mi period of (without alcohol component) This supplementary material has been provided by the authors to give readers additional information about their work.

etable. Multivariate Adjusted Hazard Ratios for All-cause and Cardiovascular Mortality According to Simple-Updated Post- MI (Without Alcohol Component), Changes From Pre- to Post-MI Period of (Without Alcohol Component) All-cause mortality Cardiovascular mortality Women Men Pooled Q1 Q2 Q3 Q4 Q5 P Tre nd 36.9 (18.5, 40.8) 44.1 (40.8, 46.8) 1.00 0.98 1.23) 38.2 (12.1, 42.9) 46.2 (42.9, 49.1) 1.00 1.21 (0.9, 1.62) 1.00 1.07 (0.89, 1.28) 49.4 (46.8, 52.1) 0.79 (0.62, 1.01) 52.0 (49.2, 54.7) 1.01 1.39) 0.88 1.07) 55.1 (52.1, 58.8) 0.79 (0.61, 1.02) 57.7 (54.7, 61.4) 1.02 1.43) 0.87 (0.71, 1.06) Post-MI score 63.9 (58.8, 90.1) 0.72 0.96) 66.8 (61.4, 93.5) 0.76 1.14) 0.73 (0.58, 0.93) c 36.9 (18.5, 40.8) Q1 Q2 Q3 Q4 Q5 P Tre nd 44.1 (40.8, 46.8).007 1.00 1.10 (0.80, 1.51) 38.2 (12.1, 42.9) 46.2 (42.9, 49.1).23 1.00 1.41 (0.91, 2.17).01 1.00 1.22 (0.95, 1.58) 49.4 (46.8, 52.1) 0.78 (0.55. 1.11) 52.0 (49.2, 54.7) 1.23 1.94) 0.97 1.28) 55.1 (52.1, 58.8) 0.78 1.12) 57.7 (54.7, 61.4) 1.31 (0.81, 2.11) 0.95 (0.71, 1.27) 63.9 (58.8, 90.1) 0.80 (0.53, 1.21) 66.8 (61.4, 93.5) 0.91 1.65) 0.85 (0.61, 1.19) d.08.98.77

Women change in Men change in Pooled -8.9 (-31.9, -4.4) -1.4 (-4.4, 0.9) 1.00 0.86 (0.65, 1.13) -7.6 (-32.8, -3.3) -0.3 (-3.3, 1.9) 1.00 0.97 (0.72, 1.3) 1.00 0.92 (0.75, 1.13) Changes of score pre- to post-mi period 3.5 (0.9, 5.8) 0.84 (0.62, 1.12) 4.3 (1.9, 6.6) 1.11 (0.83, 1.50) 0.97 1.19) 8.6 (5.8, 11.6) 0.73 0.99) 9.4 (6.6, 12.7) 0.96 (0.68, 1.34) 0.84 (0.67, 1.05) 16.9 (11.6, 44.6) 0.66 (0.47, 0.91) 17.5 (12.7, 55.7) 1.00 (0.70, 1.42) 0.81 (0.64, 1.04) e -8.9 (-31.9, - 4.4) -1.4 (-4.4, 0.9).008 1.00 1.11 1.68) -7.6 (-32.8, - 3.3) -0.3 (-3.3, 1.9).99 1.00 1.25 (0.82, 1.91).12 1.00 1.19 (0.88, 1.60) 3.5 (0.9, 5.8) 0.91 (0.59, 1.42) 4.3 (1.9, 6.6) 1.34 (0.87, 2.07) 1.12 (0.82, 1.53) 8.6 (5.8, 11.6) 0.80 1.27) 9.4 (6.6, 12.7) 0.98 (0.60, 1.60) 0.89 (0.64, 1.25) 16.9 (11.6, 44.6) 0.58 (0.35, 0.97) 17.5 (12.7, 55.7) 1.10 (0.66, 1.85) 0.82 (0.57, 1.18) f.02.91.28 Abbreviations: CI, confidence interval;, hazard ratio; Q, quintile a Adjusted for: time since MI onset, age at diagnosis (continuous), calendar year (questionnaire cycle, continuous, 2-year period), total caloric intake (quintiles of Kcal), physical activity (simple updated, quintiles of metabolic equivalents/week), aspirin use (yes or no), diabetes(yes or no), hypertension (yes or no), lipid lowering medication use(yes or no), currently married (yes or no), body mass index (<21, 21-22.9, 23-24.9, 25-27.4, 27.5-29.9, >30; calculated as weight in kilograms divided by height in meters squared), coronary artery bypass surgery (CABG, yes or no) and pre-mi diet score (quintiles) and alcohol consumption (0 g/d, 0.1-9.9 g/d, 10-29.9 g/d, or 30 g/d).

For women, additionally adjusted for post-menopausal hormone use status (pre-menopause, post-menopausal hormone never user, post-menopausal hormone current user, post-menopausal hormone past user), and smoking (never smoker or missing, past smoker, current smoker 1-14 cigarettes per day, current smoker 15-24 cigarettes per day, current smoker 25+ cigarettes per day). For men, additionally adjusted for heart failure (yes or no), left ventricular ejection fraction ( 40%, <40%, or missing), acute therapy during hospitalization (received either angioplasty or thrombolytics, or none), and smoking (never smoker or missing, past smoker, current smoker <15 cigarettes per day, current smoker 15+ cigarettes per day). b Adjusted for: time since MI onset, age at diagnosis (continuous), calendar year (questionnaire cycle, continuous, 2-year period), aspirin use (never taker, new taker, always taker), diabetes (no diabetes, new diabetes, always diabetes), hypertension (no hypertension, new hypertension, always hypertension), lipid lowering medication use (never taker, new taker, always taker), married (never married, always married, not married anymore), coronary artery bypass (CABG) surgery (never CABG, always CABG, new CABG), changes in smoking status (always never smoker, always past smokers, always current smoker 1-14 cigarettes per day post- MI period, always current smoking 15+ cigarettes per day post-mi period, quit smoking after MI 1-14 cigarettes per day pre-mi period, quit smoking after MI 15+ cigarettes per day pre-mi period), and pre-mi diet score (quintiles). For women, additionally adjusted for: changes in total caloric intake (quintiles of kilocalories), changes in physical activity (quintiles of changes in metabolic equivalents/week), changes in body mass index (quintiles of changes in kg/m 2 ), changes in alcohol consumption (quintiles of changes in g/d) and post-menopausal hormone use status (simple updated, pre-menopause, postmenopausal hormone never user, post-menopausal hormone current user, post-menopausal hormone past user). For men, additionally adjusted for: changes in total caloric intake (tertiles of kilocalories), changes in physical activity (tertiles of changes in metabolic equivalents per week), changes in body mass index (tertiles of changes; calculated as weight in kilograms divided by height in meters squared), heart failure (simple updated, yes or no), left ventricular ejection fraction (simple updated, 40%, <40%, or missing), changes in alcohol consumption (tertiles of changes in grams per day), and acute therapy during hospitalization (simple updated, received either angioplasty or thrombolytics, or none). c Fixed-effect model for heterogeneity, P=.85. d Fixed-effect model for heterogeneity, P =.35. e Fixed-effect model for heterogeneity, P =.11. f Fixed-effect model for heterogeneity, P =.11.